Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence.
- 2023-08-28
- Journal of microbiology and biotechnology 33(12)
- Jung Hyun Kang
- Zigang Dong
- Seung Ho Shin
- PubMed: 37674385
- DOI: 10.4014/jmb.2308.08016
Study Design
- Type
- Review
Soybean (Glycine max) is an important ingredient of cuisines worldwide. While there is a wealth of evidence that soybean could be a good source of macronutrients and phytochemicals with health-promoting effects, concerns regarding adverse effects have been raised. In this work, we reviewed the current clinical evidence focusing on the benefits and risks of soybean ingredients. In breast, prostate, colorectal, ovarian, and lung cancer, epidemiological studies showed an inverse association between soybean food intake and cancer risks. Soybean intake was inversely correlated with risks of type 2 diabetes mellitus (T2DM), and soy isoflavones ameliorated osteoporosis and hot flashes. Notably, soybean was one of the dietary protein sources that may reduce the risk of breast cancer and T2DM. However, soybean had adverse effects on certain types of drug treatment and caused allergies. In sum, this work provides useful considerations for planning clinical soybean research and selecting dietary protein sources for human health.
Research Insights
Soybean intake was inversely correlated with risks of type 2 diabetes mellitus (T2DM), and soy isoflavones ameliorated osteoporosis and hot flashes.
- Effect
- Beneficial
- Effect size
- Moderate
Soybean intake was inversely correlated with risks of type 2 diabetes mellitus (T2DM), and soy isoflavones ameliorated osteoporosis and hot flashes.
- Effect
- Beneficial
- Effect size
- Moderate